It has been investigated in a study that Phospholamban (PLB) (a protein that regulates the Ca2+ pump in cardiac muscle cells) inhibits the activity of SERCA2a, which appears to play a vital role in the development of DCM. The gene discussed is PLN; the disease is familial dilated cardiomyopathy.